| Uniprot No. |
P0DTC2 |
| Target Names |
S |
| Alternative Names |
S, S1, S1-RBD, Spike glycoprotein |
| Species Reactivity |
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) |
| Immunogen |
Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa) (CSB-MP3324GMY) |
| Immunogen Species |
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) |
| Conjugate |
Non-conjugated |
| Clonality |
Monoclonal |
| Isotype |
Mouse scFv fusion with human IgG1 Fc |
| Clone No. |
H6 |
| Purification Method |
Affinity-chromatography |
| Concentration |
It differs from different batches. Please contact us to confirm it. |
| Buffer |
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 |
| Form |
Liquid |
| Tested Applications |
ELISA, GICA |
| Recommended Dilution |
| Application |
Recommended Dilution |
| ELISA |
1:10000-1:50000 |
| GICA |
1:500-1:40000 |
|
| Protocols |
ELISA Protocol
CSB-RA33245A1GMY ELISA protocol |
| Storage |
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
| Description |
Recombinant anti-SARS-CoV-2 spike Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal. |
